RxDoctor Payments DataLook up a doctor →

Gina Hanissian, MD

Internal Medicine · Collierville, TNNPI 1710053327

Payments from drug & device makers

$25,103in general payments, 2019–2025

Across 1,785 payments — averaging $14.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$4K
  • AbbVie$3K
  • AstraZeneca$3K
  • Lilly USA, LLC$2K
  • Amgen$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • plus $11K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk273$3,620
AbbVie(2 entities)296$2,996
AstraZeneca124$2,919
Lilly USA, LLC182$2,140
Amgen71$1,398
Takeda Pharmaceuticals U.S.A., Inc.84$1,219
Pfizer49$832
Boehringer Ingelheim54$802
Bayer70$717
Johnson & Johnson58$681
Amarin Pharma, Inc.42$680
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC41$664
Abbott28$598
GSK55$583
Bausch Health US, LLC32$510
Biohaven Pharmaceuticals, Inc.16$383
Arbor Pharmaceuticals, Inc.43$335
Upsher-smith Laboratories LLC22$322
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)14$260
Daiichi Sankyo Inc.14$244
Teva Pharmaceuticals USA, Inc.27$224
Phathom Pharmaceuticals, Inc.21$213
Sanofi-aventis U.S. LLC12$204
Axsome Therapeutics, Inc.9$191
Biohaven Pharmaceutical Holding Company Ltd.14$144
Shire North American Group Inc9$141
Ironwood Pharmaceuticals, Inc7$127
Esperion Therapeutics, Inc.7$123
Kowa Pharmaceuticals America, Inc.6$106
Merck7$103
Dexcom, Inc.5$99
Adlon Therapeutics L.p.6$92
Hikma Pharmaceuticals USA6$92
Exact Sciences6$90
Antares Pharma, Inc.4$82
Genentech USA, Inc.4$78
Xeris Pharmaceuticals, Inc.4$78
Currax Pharmaceuticals LLC5$68
Supernus Pharmaceuticals, Inc.5$66
Harmony Biosciences LLC4$65
Mannkind Corporation4$60
Seqirus USA Inc2$57
IBSA Pharma Inc.3$56
Eisai Inc.3$56
Azurity Pharmaceuticals, Inc.3$56
Almatica Pharma LLC2$50
Corium, LLC4$48
Tris Pharma Inc3$47
Idorsia Pharmaceuticals US Inc3$40
Romark Laboratories, LC3$40
Neos Therapeutics, LP3$36
Astellas Pharma US Inc1$32
Clarus Therapeutics Inc.1$21
Evoke Pharma, Inc.1$21
Aimmune Therapeutics, Inc.1$21
Cranial Technologies, Inc1$19
Ultragenyx Pharmaceutical Inc.1$19
Gilead1$15
Avion Pharmaceuticals1$15
Iroko Pharmaceuticals, LLC1$15

How this compares

$25,103 in reported general payments places this provider in the 95th percentile of 2,216 internal medicine providers in Tennessee.

See all internal medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$234,881
Medicare patients
454
Services billed
11,280

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Collierville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →